Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Introduction: Absolute uterine factor infertility, historically considered untreatable, remained without proven effective treatment until 2014, when the first birth following uterus transplantation from a living donor occurred in Sweden. Since then, the procedure has been performed by other groups using living and deceased donors. Interest in deceased donors is increasing; however, global experience remains limited. The availability of potential deceased donors is unknown in many regions, and there is no clear consensus on inclusion criteria. Hence, the aim of this study is to determine the availability of potential deceased donors in our region and critically analyze actual inclusion criteria.
Material And Methods: A retrospective review of our organ procurement organization's database was conducted between January 1st 2015, and December 31st 2019, to identify potential deceased uterine donors. During this period, 201 women aged 18-50 were included in a multi-organ donation program after circulatory and brain death. Only brain death donors were considered, as described in the literature.
Results: After applying exclusion criteria, 14 and 48 potential deceased uterine donors were identified using standard and extended donor criteria. This corresponds to 1.8 and 6.3 deceased donors per million people throughout the entire period.
Conclusions: We believe the number of potential candidates remains low, and expanding inclusion criteria could increase organ availability, especially in those regions with emerging transplantation programs to establish cadaveric donor-based solutions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/aogs.70020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Consent to Receive Offers for Kidneys From Donors With Hepatitis C Among Pediatric Kidney Transplant Candidates in the United States.
Pediatr Transplant
November 2025
Department of Medicine, Division of Nephrology, Columbia University Vagelos College of Physicians & Surgeons, New York, New York, USA.
Background: Changes to the calculation of the Kidney Donor Profile Index (KDPI) have lowered the KDPI of hepatitis C (HCV+) donor kidneys; therefore, increasing the proportion of pediatric-prioritized kidneys that are HCV+. We aimed to study consent rates for HCV+ kidneys among pediatric kidney transplant candidates.
Methods: We identified pediatric candidates waitlisted from 2019 to 2024 and excluded those who received a living donor transplant.
The Associations Between Individual-Versus Neighborhood-level Incomes and Kidney Transplant Outcomes.
Transplantation
September 2025
Department of Surgery, NYU Langone Health, New York, NY.
Background: Disparities in posttransplant outcomes persist and worsened during the COVID-19 pandemic, disproportionately affecting individuals with social risk factors. This study examined the total and residual (ie, direct) associations between individual- and neighborhood-level income and posttransplant outcomes among deceased donor kidney transplant (DDKT) and living donor kidney transplant recipients transplanted in the United States in 2020.
Methods: This retrospective cohort study linked Organ Procurement and Transplantation Network data with estimated individual annual income from LexisNexis and neighborhood median annual household income from the American Community Survey.
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial).
BMJ Open
September 2025
Department of Gastroenterology, Hepatology, Infectious Diseases and Intoxication, University Hospital Heidelberg, Heidelberg, Germany.
Introduction: Combined vascular endothelial growth factor/programmed death-ligand 1 blockade through atezolizumab/bevacizumab (A/B) is the current standard of care in advanced hepatocellular carcinoma (HCC). A/B substantially improved objective response rates compared with tyrosine kinase inhibitor sorafenib; however, a majority of patients will still not respond to A/B. Strong scientific rationale and emerging clinical data suggest that faecal microbiota transfer (FMT) may improve antitumour immune response on PD-(L)1 blockade.
View Article and Find Full Text PDFBiomechanical superiority of novel dynamic tape over standard tape suture in distal triceps tendon repair: a human cadaveric study testing an intense early rehabilitation protocol.
Arch Orthop Trauma Surg
September 2025
Medical Faculty, University of Zurich (UZH), Zurich, Switzerland.
Background: Distal triceps tendon rupture is related to high complication rates with up to 25% failures. Elbow stiffness is another severe complication, as the traditional approach considers prolonged immobilization to ensure tendon healing. Recently, a dynamic tape was designed, implementing a silicone-infused core for braid shortening and preventing repair elongation during mobilization, thus maintaining constant tissue approximation.
View Article and Find Full Text PDFNasal microbiome inhabitants with anti- activity.
Microbiol Spectr
September 2025
Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, USA.
Unlabelled: (SA) colonizes most mammals but also represents a danger in clinical settings because it evolves resistance against antibiotics, and SA infections represent a leading cause of death worldwide. SA nasal carriage provides the bacterial reservoir for opportunistic infection because clinical strains often match the patient's own nasally carried strain. The global SA carriage rate is typically reported as 25%-30% after sampling subjects once or twice and defining carrier status using culture-based methods.
View Article and Find Full Text PDF